|
市場調査レポート
商品コード
1629595
介護ソフトウェア市場：製品別、提供形態別、エンドユーザー別、地域別Long-term Care Software Market, By Product, By Mode of Delivery, By End User, By Geography |
||||||
カスタマイズ可能
|
|||||||
| 介護ソフトウェア市場：製品別、提供形態別、エンドユーザー別、地域別 |
|
出版日: 2024年11月26日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界の介護ソフトウェア市場は、2024年には54億米ドルと推定され、2024年から2031年までのCAGRは7.6％を示し、2031年には90億1,000万米ドルに達すると予測されます。
| レポート範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2023 | 2024年の市場規模 | 54億米ドル |
| 実績データ | 2019年から2023年まで | 予測期間 | 2024年から2031年まで |
| 予測期間2024年から2031年 CAGR： | 7.60% | 2031年の価値予測 | 90億1,000万米ドル |
介護ソフトウェアは、高齢者向け住宅施設、成人デイケア、介護付き有料老人ホーム、介護施設の管理を支援します。投薬管理、請求、サービス時間の追跡など、入居者に関連する管理業務を効率化します。慢性疾患や障害を抱えやすい老年人口が世界的に増加していることが、こうした施設の必要性を高めています。さらに、入院治療にかかる医療費の増加により、質の高い在宅ケアに対する需要も高まっています。このため介護事業者は、生産性と規制遵守を維持しながら質の高いサービスを提供するためのソフトウェアソリューションへの投資を促しています。高齢者介護の選択肢に対する意識が高まるにつれ、同市場は着実に成長すると予想されます。
市場力学：
世界の介護ソフトウェア市場を刺激する主な促進要因としては、高齢者の障害につながる慢性疾患の蔓延、在宅介護ソリューションの採用拡大を促す医療費の増加、ヘルスケアにおけるデジタルツールの使用を義務付ける規制の施行などが挙げられます。しかし、こうしたソフトウェアのインストールやメンテナンスにかかるコストが高いことや、地域によっては熟練した看護スタッフが不足していることが、普及を遅らせています。より堅牢なクラウドベースバージョンの開発と、健康パラメーターを遠隔監視するためのAI機能の統合にチャンスがあります。市場開拓企業は、高齢化が進む新興国でのビジネスチャンスを模索することもできます。
本調査の主な特徴
当レポートでは、世界の介護ソフトウェア市場を詳細に分析し、2023年を基準年とした予測期間（2024年～2031年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の介護ソフトウェア市場の主要企業をプロファイルしています。
主要企業には、Abbott、Medtronic、Getinge AB、Abiomed、Terumo Corporation、Boston Scientific、F. Hoffmann-La Roche Ltd、Bayer AG、Viatris Inc.、Par Pharmaceutical、AstraZeneca、Zoll Medical Corporation、Xenios AG（Fresenius Medical Careの一部）、Windtree Therapeutics、Chiesi Farmaceutici S.p.A.などがあります。
このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。
利害関係者は、世界の介護ソフトウェア市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- PORTERの分析
- 合併と買収のシナリオ
- 業界動向
第4章 世界の介護ソフトウェア市場、製品別、2019年-2031年
- 電子健康記録（EHR）
- 遠隔患者モニタリングシステム
- 収益サイクル管理（RCM）
- 臨床意思決定支援システム
- 電子処方
- リアルタイム位置情報システム
- 電子薬剤投与記録（eMAR）
- 電子処方
- 課金、請求書発行、スケジュール管理ソフトウェア
- その他
第5章 世界の介護ソフトウェア市場、提供形態別、2019年-2031年
- クラウドベース
- ウェブベース
- オンプレミス
第6章 世界の介護ソフトウェア市場、エンドユーザー別、2019年-2031年
- 在宅ヘルスケア機関
- ホスピス・緩和ケア
- 老人ホーム
- 介護施設
- その他
第7章 世界の介護ソフトウェア市場、地域別、2019年-2031年
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第8章 競合情勢
- Abbott
- Medtronic
- Getinge AB
- Abiomed
- Terumo Corporation
- Boston Scientific
- Hoffmann-La Roche Ltd
- Bayer AG
- Viatris Inc.
- Par Pharmaceutical
- AstraZeneca
- Zoll Medical Corporation
- Xenios AG（part of Fresenius Medical Care）
- Windtree Therapeutics
- Chiesi Farmaceutici S.p.A.
第9章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- 一貫した機会マップ
第10章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
The global long-term care software market is estimated to be valued at USD 5.40 Bn in 2024 and is expected to reach USD 9.01 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 5.40 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.60% | 2031 Value Projection: | US$ 9.01 Bn |
Long-term care software helps in the management of senior housing facilities, adult daycare, assisted living, and nursing homes. It streamlines administrative tasks related to residents such as medication management, billing, and tracking service hours. The rising geriatric population globally prone to chronic diseases and disabilities has boosted the need for such facilities. Additionally, the demand for quality care at home has also been on the rise owing to greater medical costs of inpatient care. This has prompted care providers to invest in software solutions that aid in providing quality services while maintaining productivity and regulatory compliance. The market is expected to grow steadily as awareness about senior care options increases.
Market Dynamics:
The key drivers fueling the global long-term care software market include growing prevalence of chronic diseases leading to disabilities among elderly, increasing healthcare costs prompting greater adoption of home-based care solutions, and implementation of regulations mandating use of digital tools in healthcare. However, high installation and maintenance costs of such software as well as lack of skilled nursing staff in some regions are slowing down adoption. The opportunity lies in the development of more robust cloud-based versions and integration of AI capabilities for remotely monitoring health parameters. Market players could also explore opportunities in developing countries witnessing rise in aging population.
Key Features of the Study:
This report provides in-depth analysis of the global long-term care software market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global long-term care software market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott, Medtronic, Getinge AB, Abiomed, Terumo Corporation, Boston Scientific, F. Hoffmann-La Roche Ltd, Bayer AG, Viatris Inc., Par Pharmaceutical, AstraZeneca, Zoll Medical Corporation, Xenios AG (part of Fresenius Medical Care), Windtree Therapeutics, and Chiesi Farmaceutici S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global long-term care software market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global long-term care software market
Market Segmentation
- By Product Insights (Revenue, USD Bn 2019 - 2031)
- Electronic Health Records (EHR)
- Remote Patient Monitoring Systems
- Revenue Cycle Management (RCM)
- Clinical Decision Support Systems
- E-prescribing
- Real-Time Location Systems
- Electronic Medication Administration Record (eMAR)
- E-prescribing
- Billing, Invoicing, and Scheduling Software
- Others
- By Mode of Delivery Insights (Revenue, USD Bn, 2019 - 2031)
- Cloud-Based
- Web-Based
- On-Premise
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Home Healthcare Agencies
- Hospice & Palliative Care
- Nursing Homes
- Assisted Living Facilities
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott
- Medtronic
- Getinge AB
- Abiomed
- Terumo Corporation
- Boston Scientific
- Hoffmann-La Roche Ltd
- Bayer AG
- Viatris Inc.
- Par Pharmaceutical
- AstraZeneca
- Zoll Medical Corporation
- Xenios AG (part of Fresenius Medical Care)
- Windtree Therapeutics
- Chiesi Farmaceutici S.p.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Long-term Care Software Market, By Product
- Global Long-term Care Software Market, By Mode of Delivery
- Global Long-term Care Software Market, By End User
- Global Long-term Care Software Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Long-term Care Software Market, By Product, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Electronic Health Records (EHR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Remote Patient Monitoring Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Revenue Cycle Management (RCM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinical Decision Support Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Real-Time Location Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Electronic Medication Administration Record (eMAR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- E-prescribing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Billing, Invoicing, and Scheduling Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Long-term Care Software Market, By Mode of Delivery, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cloud-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Web-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- On-Premise
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Long-term Care Software Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Home Healthcare Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospice & Palliative Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nursing Homes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Assisted Living Facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Long-term Care Software Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Mode of Delivery, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abiomed
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Hoffmann-La Roche Ltd
- Bayer AG
- Viatris Inc.
- Par Pharmaceutical
- AstraZeneca
- Zoll Medical Corporation
- Xenios AG (part of Fresenius Medical Care)
- Windtree Therapeutics
- Chiesi Farmaceutici S.p.A.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
